REVERSED
1600 Biotechnology and Organic Chemistry
1627 Ex Parte Borgers et al 12/108,262 GRIMES 103(a) Glaxo Smith Kline c/o The Nath Law Group EXAMINER WANG, SHENGJUN
However, the Specification’s disclosure is presumed to be accurate, and the burden is on the Examiner to provide evidence that it is not. Cf. In re Marzocchi, 439 F.2d 220, 224 (CCPA 1971) (“[It] is incumbent upon the Patent Office, whenever a rejection on this basis is made, to explain why it doubts the truth or accuracy of any statement in a supporting disclosure and to back up assertions of its own with acceptable evidence or reasoning which is inconsistent with the contested statement.”); In re Langer, 503 F.2d 1380, 1391 (CCPA 1974) (“[A] specification which contains a disclosure of utility which corresponds in scope to the subject matter sought to be patented must be taken as sufficient to satisfy the utility requirement of § 101 for the entire claimed subject matter unless there is reason for one skilled in the art to question the objective truth of the statement of utility or its scope.”).
Marzocchi, In re, 439 F.2d 220, 169 USPQ 367 (CCPA 1971) . . . 2107.01, 2107.02, 2124, 2163, 2163.04, 2164.03, 2164.04, 2164.08
Langer, In re, 503 F.2d 1380, 183 USPQ 288 (CCPA 1974) . . . . . . . .2107.02, 2107.03, 2124
1641 Ex Parte Gjerde 12/004,726 WALSH 103(a) PHYNEXUS, INC. EXAMINER SHIBUYA, MARK LANCE
1700 Chemical & Materials Engineering
1714 Ex Parte Schneider et al 10/852,927 FRANKLIN 103(a) WHIRLPOOL PATENTS COMPANY - MD 0750 EXAMINER BLAN, NICOLE R
1715 Ex Parte Hass et al 10/489,090 HANLON 102(b)/103(a) NOVAK DRUCE DELUCA + QUIGG LLP EXAMINER GAMBETTA, KELLY M
1713 Ex Parte Shatwell 10/504,204 PAK 103(a) MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP EXAMINER TRAN, BINH X
See also, W.L. Gore & Assocs. v. Garlock, Inc., 721 F.2d 1540, 1553 (Fed. Cir. 1983), cert. denied, 469 U.S. 851 (1984) (“To imbue one of ordinary skill in the art with knowledge of the invention . . ., when no prior art reference or references of record convey or suggest that knowledge, is to fall victim to the insidious effect of a hindsight syndrome wherein that which only the invention taught is used against its teacher.”).
W.L. Gore & Assoc., Inc. v. Garlock, Inc., 721 F.2d 1540, 220 USPQ 303 (Fed. Cir. 1983). . . . 2132, 2133.03(a), 2133.03(c), 2141.01, 2141.02, 2144.08, 2164.08, 2165.04, 2173.05(b)
3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3643 Ex Parte Swank 10/990,891 HORNER 112(2)/103(a) Patent Procurement Services EXAMINER PARSLEY, DAVID J
3679 Ex Parte Jamison et al 11/256,596 BARRETT 103(a) HARNESS, DICKEY & PIERCE, P.L.C. EXAMINER DUNWOODY, AARON M
AFFIRMED-IN-PART
3700 Mechanical Engineering, Manufacturing, and Products & Design
3767 Ex Parte Alholm et al 11/510,320 LEBOVITZ 102(b) TAFT STETTINIUS & HOLLISTER LLP EXAMINER HAYMAN, IMANI N
3773 Ex Parte Miles et al 10/186,307 KAUFFMAN 102(b)/103(a) HOLLAND & HART EXAMINER EREZO, DARWIN P
AFFIRMED
1600 Biotechnology and Organic Chemistry
1628 Ex Parte Hovey et al 11/472,556 GRIMES 103(a) Elan Drug Delivery, Inc. c/o Foley & Lardner EXAMINER SZNAIDMAN, MARCOS L
2100 Computer Architecture and Software
2169 Ex Parte Gilmour et al 10/135,254 LUCAS Concurring-In-Part THOMAS 101/103(a) BLAKELY, SOKOLOFF, TAYLOR & ZAFMAN LLP EXAMINER TRUONG, CAM Y T
3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3627 Ex Parte Vernon 11/180,796 KIM 102(e) FISH & RICHARDSON P.C. (BO) EXAMINER SHAAWAT, MUSSA A
3635 Ex Parte Elliott et al 10/773,757 KERINS 102(b)/103(a) JERRY TURNER SEWELL EXAMINER NGUYEN, CHI Q
REHEARING
DENIED
1700 Chemical & Materials Engineering
1726 Ex Parte Guthrie 10/816,403 GARRIS 102/103 M. P. Williams EXAMINER WALKER, KEITH D
